These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6603557)
1. Cytotoxic responses induced by peptidoglycans with or without in vivo antitumor activity. Goguel AF; Payelle B; Lespinats G; Nauciel C J Natl Cancer Inst; 1983 Aug; 71(2):325-30. PubMed ID: 6603557 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of one particular subset of natural killer cells by peptidoglycans extracted from gram-positive bacteria. Goguel AF; Payelle B; Quan PC; Lespinats G J Natl Cancer Inst; 1984 Sep; 73(3):697-703. PubMed ID: 6590915 [TBL] [Abstract][Full Text] [Related]
3. Peptidoglycans extracted from gram-positive bacteria: expression of antitumor activity according to peptide structure and route of injection. Goguel AF; Lespinats G; Nauciel C J Natl Cancer Inst; 1982 Apr; 68(4):657-63. PubMed ID: 6803057 [TBL] [Abstract][Full Text] [Related]
4. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines. Rees RC; Reynolds CW; Herberman RB Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862 [TBL] [Abstract][Full Text] [Related]
5. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT). Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798 [TBL] [Abstract][Full Text] [Related]
6. Different antitumor immunity roles of cytokine activated T lymphocytes from naive murine splenocytes and from dendritic cells-based vaccine primed splenocytes: implications for adoptive immunotherapy. Zhang S; Wang Q; Li WF; Wang HY; Zhang HJ; Zhu JJ Eksp Onkol; 2004 Mar; 26(1):55-62. PubMed ID: 15112581 [TBL] [Abstract][Full Text] [Related]
7. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells. Li T; Harada M; Tamada K; Abe K; Nomoto K Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518 [TBL] [Abstract][Full Text] [Related]
8. [Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo]. Ge W; Li CH; Zhang W; Han Q; Deng WM; Chen L; You SG; Zhao CH Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):277-80. PubMed ID: 15182535 [TBL] [Abstract][Full Text] [Related]
9. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VII. Kinetic studies on various parameters of effects induced with suppressor cells. Deutsch O; Devens B; Naor D Isr J Med Sci; 1980 Jul; 16(7):530-7. PubMed ID: 6447122 [TBL] [Abstract][Full Text] [Related]
10. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [TBL] [Abstract][Full Text] [Related]
11. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma. Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the in vitro secondary cell-mediated cytotoxic response against syngeneic FBL-3 leukemia by macrophages. Igarashi T; Teranishi T; Rodrigues D; Yamamura Y Microbiol Immunol; 1980; 24(6):599-72. PubMed ID: 6968022 [TBL] [Abstract][Full Text] [Related]
14. Study of adjuvant and mitogenic activities of bacterial peptidoglycans with different structures. Guenounou M; Goguel AF; Nauciel C Ann Immunol (Paris); 1982; 133D(1):3-13. PubMed ID: 6818895 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells. Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA Cancer Gene Ther; 2000 Jul; 7(7):1060-8. PubMed ID: 10917209 [TBL] [Abstract][Full Text] [Related]
17. Natural cytotoxic cells against solid tumors in mice: a comparison with natural killer cells. Stutman O; Lattime EC; Figarella EF Fed Proc; 1981 Oct; 40(12):2699-704. PubMed ID: 7286250 [TBL] [Abstract][Full Text] [Related]
18. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570). Liepins A; Nowicky JW Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312 [TBL] [Abstract][Full Text] [Related]
19. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy. Merritt RE; Yamada RE; Crystal RG; Korst RJ J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342 [TBL] [Abstract][Full Text] [Related]
20. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells. Le Gros GS; Herbert AG; Watson JD Immunology; 1984 Jan; 51(1):103-13. PubMed ID: 6606615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]